A detailed history of Israel Englander (Millennium Management LLC) transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 562,474 shares of CRBU stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
562,474
Previous 720,522 21.94%
Holding current value
$1.01 Million
Previous $1.18 Million 7.2%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.56 - $2.73 $246,554 - $431,471
-158,048 Reduced 21.94%
562,474 $1.1 Million
Q2 2024

Aug 14, 2024

BUY
$1.62 - $5.05 $970,433 - $3.03 Million
599,033 Added 493.08%
720,522 $1.18 Million
Q1 2024

May 15, 2024

BUY
$4.82 - $8.26 $517,065 - $886,091
107,275 Added 754.71%
121,489 $624,000
Q4 2023

Feb 14, 2024

SELL
$3.58 - $6.25 $2.54 Million - $4.43 Million
-708,355 Reduced 98.03%
14,214 $81,000
Q2 2023

Aug 14, 2023

BUY
$4.04 - $5.47 $1.61 Million - $2.17 Million
397,554 Added 122.32%
722,569 $3.07 Million
Q1 2023

May 15, 2023

BUY
$4.3 - $7.78 $365,379 - $661,082
84,972 Added 35.4%
325,015 $1.73 Million
Q4 2022

Feb 14, 2023

BUY
$5.57 - $11.01 $21,878 - $43,247
3,928 Added 1.66%
240,043 $1.51 Million
Q3 2022

Nov 14, 2022

BUY
$5.34 - $12.79 $1.13 Million - $2.7 Million
211,199 Added 847.64%
236,115 $2.49 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $110M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.